These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 15169752)
1. Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model. Cui X; Parent C; Macarthur H; Ochs SD; Gerstenberg E; Solomon S; Fitz Y; Danner RL; Banks SM; Natanson C; Salvemini D; Eichacker PQ J Appl Physiol (1985); 2004 Oct; 97(4):1349-57. PubMed ID: 15169752 [TBL] [Abstract][Full Text] [Related]
2. Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines. Macarthur H; Couri DM; Wilken GH; Westfall TC; Lechner AJ; Matuschak GM; Chen Z; Salvemini D Crit Care Med; 2003 Jan; 31(1):237-45. PubMed ID: 12545022 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model. Haley M; Parent C; Cui X; Kalil A; Fitz Y; Correa-Araujo R; Natanson C; Danner RL; Banks SM; Eichacker PQ J Appl Physiol (1985); 2005 Jun; 98(6):2155-62. PubMed ID: 15677732 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Cuzzocrea S; Mazzon E; Dugo L; Caputi AP; Aston K; Riley DP; Salvemini D Br J Pharmacol; 2001 Jan; 132(1):19-29. PubMed ID: 11156557 [TBL] [Abstract][Full Text] [Related]
5. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Eichacker PQ; Parent C; Kalil A; Esposito C; Cui X; Banks SM; Gerstenberger EP; Fitz Y; Danner RL; Natanson C Am J Respir Crit Care Med; 2002 Nov; 166(9):1197-205. PubMed ID: 12403688 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock. Cuzzocrea S; Mazzon E; Di Paola R; Genovese T; Serraino I; Dugo L; Cuzzocrea E; Fulia F; Caputi AP; Salvemini D Crit Care Med; 2004 Jan; 32(1):157-67. PubMed ID: 14707575 [TBL] [Abstract][Full Text] [Related]
7. Sophorolipids improve sepsis survival: effects of dosing and derivatives. Hardin R; Pierre J; Schulze R; Mueller CM; Fu SL; Wallner SR; Stanek A; Shah V; Gross RA; Weedon J; Nowakowski M; Zenilman ME; Bluth MH J Surg Res; 2007 Oct; 142(2):314-9. PubMed ID: 17719064 [TBL] [Abstract][Full Text] [Related]
9. Effects of pentoxifylline on inflammation and lung dysfunction in ventilated septic animals. Oliveira-Júnior IS; Oliveira WR; Cavassani SS; Brunialti MK; Salomao R J Trauma; 2010 Apr; 68(4):822-6. PubMed ID: 20065880 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Rice TW; Wheeler AP; Bernard GR; Vincent JL; Angus DC; Aikawa N; Demeyer I; Sainati S; Amlot N; Cao C; Ii M; Matsuda H; Mouri K; Cohen J Crit Care Med; 2010 Aug; 38(8):1685-94. PubMed ID: 20562702 [TBL] [Abstract][Full Text] [Related]
12. Recombinant activated protein C induces dose-dependent changes in inflammatory mediators, tissue damage, and apoptosis in in vivo rat model of sepsis. Shires GT; Fisher O; Murphy P; Williams S; Barber A; Johnson G; Davis B; Pahulu S Surg Infect (Larchmt); 2007 Jun; 8(3):377-86. PubMed ID: 17635061 [TBL] [Abstract][Full Text] [Related]
13. Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Tidswell M; Tillis W; Larosa SP; Lynn M; Wittek AE; Kao R; Wheeler J; Gogate J; Opal SM; Crit Care Med; 2010 Jan; 38(1):72-83. PubMed ID: 19661804 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotection against hypoxia-ischemia in neonatal rat brain by novel superoxide dismutase mimetics. Shimizu K; Rajapakse N; Horiguchi T; Payne RM; Busija DW Neurosci Lett; 2003 Jul; 346(1-2):41-4. PubMed ID: 12850543 [TBL] [Abstract][Full Text] [Related]
15. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis. Cui X; Li Y; Moayeri M; Choi GH; Subramanian GM; Li X; Haley M; Fitz Y; Feng J; Banks SM; Leppla SH; Eichacker PQ J Infect Dis; 2005 Feb; 191(3):422-34. PubMed ID: 15633102 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial. Dellinger RP; Tomayko JF; Angus DC; Opal S; Cupo MA; McDermott S; Ducher A; Calandra T; Cohen J; Crit Care Med; 2009 Nov; 37(11):2929-38. PubMed ID: 19770753 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic and curative effects of recombinant human superoxide dismutase in lethal rat endotoxemia. Schneider J Arzneimittelforschung; 1988 Sep; 38(9):1381-6. PubMed ID: 3066366 [TBL] [Abstract][Full Text] [Related]